For example, in the HUVEC system, LUT-7G reduces the expression of IL-1β, which has been demonstrated to be a clinically applicable intervention to improve the cardiovascular outcomes, leading to a new use of anti-inflammatory therapies for atherosclerosis [31]. The gene discussed is IL1B; the disease is atherosclerosis.